Nipro Corp. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
300,752
325,084
366,650
359,699
395,397
426,399
Cost of Goods Sold (COGS) incl. D&A
213,220
225,525
250,773
244,602
266,606
294,357
Gross Income
87,532
99,559
115,877
115,097
128,791
132,042
SG&A Expense
55,146
82,987
90,792
86,296
101,794
108,214
EBIT
32,386
16,572
25,085
28,801
26,997
23,828
Unusual Expense
642
1,037
3,414
3,713
4,527
3,066
Non Operating Income/Expense
3,069
7,841
8,478
2,382
1,772
3,335
Interest Expense
3,857
4,066
4,501
5,012
4,360
3,756
Pretax Income
12,891
19,908
26,284
18,324
17,026
21,233
Income Tax
9,790
7,097
6,806
6,720
4,727
9,357
Consolidated Net Income
3,101
12,811
19,478
11,604
12,298
11,876
Net Income
2,861
12,470
19,718
11,346
11,830
12,136
Net Income After Extraordinaries
2,861
12,470
19,718
11,346
11,830
12,136
Net Income Available to Common
2,861
12,470
19,718
11,346
11,829
12,136
EPS (Basic)
18.19
80.95
116.22
67.57
71.14
73.68
Basic Shares Outstanding
157
154
170
168
166
165
EPS (Diluted)
16.29
80.95
114.67
61.33
64.51
66.75
Diluted Shares Outstanding
176
154
172
185
183
182
EBITDA
62,364
49,632
58,918
62,836
62,993
62,452
Non-Operating Interest Income
748
767
733
520
577
816
Minority Interest Expense
240
341
240
258
468
260
Equity in Affiliates (Pretax)
-
168
95
112
113
78

About Nipro

View Profile
Address
3-9-3 Honjo-Nishi
Osaka Osaka 531
Japan
Employees -
Website http://www.nipro.co.jp
Updated 07/08/2019
Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products.